InvestorsHub Logo
Post# of 252300
Next 10
Followers 78
Posts 3639
Boards Moderated 0
Alias Born 01/17/2003

Re: DewDiligence post# 244777

Friday, 12/16/2022 9:36:53 PM

Friday, December 16, 2022 9:36:53 PM

Post# of 252300
For 131I-omburtamab, Serious Adverse Events (“SAE”) was found in 40.6% of the patients and were mostly related to myelosuppression.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.